Business Wire

Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries

Del

Takeda Pharmaceutical Company Limited (TOKYO:4502), (“Takeda”) today announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With this funding, Takeda will develop, license and supply at least 50 million doses per year of Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries. The vaccine will be manufactured at Takeda’s facility in Hikari, Japan. This effort is aligned with Takeda’s strategy to utilize innovation and partnerships to address critical unmet needs in global public health, and the Sustainable Development Goals adopted by the United Nations in September 2015.

Christophe Weber, President and CEO of Takeda said: “Takeda is honored to partner with the Gates Foundation to support the polio endgame. This represents a major commitment by a Japanese company to the health of children in developing countries around the world.”

Under the terms of the agreement, the Gates Foundation will provide a $38 million grant to Takeda to leverage its innovative vaccine manufacturing platform to develop and license a safe and effective Sabin-strain inactivated polio vaccine, and make at least 50 million doses per year available at an affordable price for developing countries receiving Gavi support. Gavi, the Vaccine Alliance, brings together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries. Takeda’s sIPV was originally licensed from the Japan Polio Research Institute, which is now a part of BIKEN.

Chris Elias, President, Global Development at the Bill & Melinda Gates Foundation stated, “In 2016, the world is closer than ever to eradicating polio. To eradicate polio we need to ensure every last child is protected from the disease - this partnership will help to ensure that the world has enough vaccine to get the job done and maintain a polio free world.”

“Takeda’s polio program demonstrates our commitment to tackle the most important public health problems and promote access for the populations in greatest need, joining our programs in dengue, norovirus, and hand, foot and mouth disease,” added Dr. Rajeev Venkayya, President of Takeda’s Vaccine Business Unit. “We’re excited about this partnership with the Bill & Melinda Gates Foundation, and the potential to reach hundreds of millions of children around the globe as part of the final push to eradicate polio.”

About Polio
Polio (poliomyelitis) is a crippling and potentially fatal infectious disease caused by the poliovirus. There is no cure, but there are safe and effective vaccines. The strategy to eradicate polio is therefore based on preventing infection by immunizing every child until transmission stops and the world is polio-free. It invades the nervous system and can cause irreversible paralysis in a matter of hours. Polio can strike at any age, but it mainly affects children under five years old. 1

Takeda’s Commitment to Vaccines
Vaccines prevent more than two million deaths each year and have transformed global public health. For 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue and norovirus. Our team brings an outstanding track record and a wealth of knowledge in vaccine development, manufacturing and global access to advance a pipeline of vaccines to address some of the world’s most pressing public health needs.

About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.

1 World Health Organization, http://www.polioeradication.org/Polioandprevention.aspx

Contact information

Takeda Pharmaceutical Company Limited
For media outside of Japan:
Paul Newman, +1 617 444 4418
paul.newman@takeda.com
For Japanese media:
Tsuyoshi Tada, +81-3-3278-2417
tsuyoshi.tada@takeda.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Hisense's Zhou Houjian and Huawei's Kevin Ho to Keynote CES Asia; Focus on Mobility, 5G and Connectivity24.5.2018 15:00Pressemelding

The Consumer Technology AssociationTM (CTA) today announced that Hisense Chairman Zhou Houjian and Huawei’s president of Handset Product Line Kevin Ho will deliver separate keynote addresses at the upcoming CES AsiaTM 2018. As CES Asia drives the expansion of technology into new areas like artificial intelligence, vehicle technology, AR, VR and more, Chairman Zhou and Mr. Ho will discuss the future of innovation at their respective companies through connectivity and mobility during Asia’s premier tech event. “Hisense and Huawei have become major global brands by challenging the status quo and creating innovative product solutions that engage, entertain and connect consumers around the world,” said Gary Shapiro, president and CEO, CTA. “We are thrilled to welcome Chairman Zhou and Mr. Ho to the CES Asia keynote stage and are eager to learn from these experts who are leading the charge to harness the potential of 5G through various implementation strategies and connection opportunities.”

Maximum Cryptocurrencies Available for EU Traders in Libertex24.5.2018 14:29Pressemelding

Libertex trading platform, operated by Indication Investments Ltd, announces that starting from May 23rd 2018, European traders can perform operations with 34 new cryptocurrency CFD instruments. This means that Libertex became one of the leading applications and trading platforms for EU traders in terms of amount of cryptocurrencies available. Andrew Nikolaev, Libertex Executive director highlighted: “Cryptocurrencies are one of the main trends in financial industry for the past couple of years. The demand for these assets grows significantly. We are happy to satisfy the demand of European traders for new innovative crypto-instruments launching them in our cutting edge Libertex platform”. Launch of cryptocurrency pairs in Libertex for EU traders follows Circular from Cyprus financial regulator - CySec issued on May 15th 2018, that introduces new rules for governing derivatives on virtual currencies. According to this Circular, CFDs on virtual currencies are considered as financial inst

Andersen Global’s Middle East Expansion Continues with Solutions Bridge in Kuwait24.5.2018 13:30Pressemelding

Solutions Bridge, an Accounting and Corporate Secretarial Services firm in Kuwait City, has signed a Collaboration Agreement with Andersen Global. The addition of a location in Kuwait demonstrates Andersen Global’s growth in the Middle East, which is a significant market for the organization. “Having a strong practice in Kuwait is important to our regional success and this is an extraordinary opportunity to continue providing best-in-class services globally,” commented Mark Vorsatz, Global Chairman and Andersen Tax LLC CEO. “There are many changes in the Middle East currently and the development of tax laws is a major factor in the region. The addition of Solutions Bridge, one of the largest accounting firms in Kuwait, positions us for continued opportunities for expansion.” Formed by former professionals of Andersen in Kuwait, Solutions Bridge is led by Partner Fouad Al Hourani. The firm provides accounting and corporate secretarial services for both individuals and corporations in a

Workiva Signs OEM Agreement with SAP to Offer SAP® Cloud Platform Integration with the Workiva Wdesk Platform24.5.2018 13:00Pressemelding

Workiva (NYSE:WK), a leader in cloud-based data collaboration, reporting and compliance solutions, today announced it has signed an original equipment manufacturer (OEM) agreement with SAP (NYSE:SAP). Through this agreement, Workiva is partnering with SAP to provide a first-party integration with the Wdesk platform using the SAP® Cloud Platform Integration service. The bundled solutions are expected to provide customers with powerful linking, auditability and control features. “Today’s announcement demonstrates that Workiva and SAP are committed to providing customers with a rich integration experience,” said Matt Rizai, chairman and CEO of Workiva. “Through our OEM partnership, we will help customers all over the world improve the value of their business data.” After users integrate their SAP business data directly into the Wdesk platform, they can benefit from the full capabilities of Wdesk, including synchronized data, dynamic commentary, controlled collaboration, granular permissio

M-Brain Appoints New CEO24.5.2018 12:25Pressemelding

M-Brain, a global leader in market and media intelligence solutions, has appointed Christian Cedercreutz Chief Executive Officer as of 13.8.2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180524005676/en/ M-Brain, a global leader in market and media intelligence solutions, has appointed Christian Cedercreutz Chief Executive Officer as of 13.8.2018. (Photo: Business Wire) Christian holds a Master of Economics degree from Hanken School of Economics in Helsinki. His career has been built with IBM over the past 20 years, in which he has held various management positions in five different European countries. Christian brings strong consultative selling experience and has over the years worked across the IBM Corporation in roles such as leading global client relationships, and leading SW and HW technology businesses in Finland. His most recent role has been to lead the cognitive SW solutions (Watson) business in Finland. Simu

IBIN Introduced into Billion Dollar Blockchain Market by Hybrid Stock Exchange24.5.2018 12:13Pressemelding

Hybrid Stock Exchange, a blockchain based trading platform using the released IBIN as a blockshare identifier, are all set to adopt innovative features to sustain the needs of the ever growing industry. Watch the HYBSE trailer here: http://www.hybse.com The International Securities Identification Number (ISIN) is a 12 character code that uniquely identifies a specific security, such as stocks, and is the most popular global securities identifier. With the pre-registration for issuers and users opened, the DIM Ecosystem introduces the International Blockshare Identification Number (IBIN), a 13 digit, unique serial number used by a company for listing on the Hybrid Stock Exchange or other Blockchain Exchanges. Tradable securities on HYBSE currently include Cryptonized equity, Cryptocurrencies, Exchange-traded commodities, index, and more. Any issuers are able to apply for their IBIN at no charge. This limited time offer is available until August 31, 2018 or for the first 75 companies tha